At ImmunoQs, we believe every cancer patient is unique. Our core mission is to enhance patient outcomes in modern cancer therapies.
We are a spin-off company from the Agency for Science, Technology and Research (A*STAR), Singapore. We offer comprehensive suites of specialized services to clinicians, scientists, and drug developers, focusing on spatial omics, immune monitoring and digital analytics, meticulously tailored to address specific clinical needs and scientific questions in immuno-oncology.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 73 Ayer Rajah Crescent, #02-11,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ImmunoQs.com/
- HQ
- Singapore
- Competitors
- initd.sg, A*STAR Bioinformatics Institute (A*STAR BII), Parker Institute for Cancer Immunotherapy, Nature Portfolio, TicketMeta, A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), Singapore Week of Innovation and Technology (SWITCH), immin, Núclea, A*STAR - Agency for Science, Technology and Research.
Immunoqs Questions
Immunoqs's website is https://ImmunoQs.com/
Immunoqs's LinkedIn profile is https://sg.linkedin.com/company/immunoqs
Immunoqs has
8 employees.
View email and phone details for 8
employees at Immunoqs.
Immunoqs's industry is
Biotechnology Research
Immunoqs's top competitors are
Initd.sg,
A*star Bioinformatics Institute (A*star Bii),
Parker Institute For Cancer Immunotherapy,
Nature Portfolio,
Ticketmeta,
A*star Institute Of Molecular And Cell Biology (A*star Imcb),
Singapore Week Of Innovation And Technology (Switch),
Immin,
Núclea,
A*star - Agency For Science, Technology And Research.
Immunoqs's categories are Biotechnology Research
Immunoqs's founding year is 2022
